ZPHC Cabergoline 0.25mg

ZPHC Cabergoline 0.25mg | Dopamine Receptor Agonist

Main function: lowers serum prolactin by activating pituitary D₂ receptors, keeping levels in the low-normal range.
When it’s used: Trenbolone / Nandrolone studies, hyper-prolactinaemia models, libido or erectile-function research.
Typical research dosing: 0.25 mg twice weekly
(bloodwork-guided ceiling ≈ 1 mg / week).
Expected benefits: prevents gynecomastia, water retention, mood swings, low libido and “tren cough” associated with high prolactin.
Monitoring advice: track prolactin, blood pressure and mild CNS side-effects (yawning, light-headedness).
QC: ≥ 99 % API purity (HPLC) • GMP tablet press • tamper-evident cap with scratch-code authenticity.

$66.00

Cabergoline ZPHC — 0.25 mg × 50 tablets

ZPHC Cabergoline 0.25mg is an orally active synthetic ergot derivative containing Cabergoline as its active pharmaceutical ingredient. Functioning as a potent, long-acting, selective dopamine $D_2$ receptor agonist, Cabergoline acts directly upon the $D_2$ receptors of pituitary lactotroph cells to inhibit the synthesis and secretion of prolactin.

Due to its high selectivity for $D_2$ receptors relative to $D_1$ , $\alpha_1$ , and $\alpha_2$ -adrenergic or $5\text{-HT}_1$ and $5\text{-HT}_2$ serotonergic receptors, Cabergoline offers targeted prolactin suppression with an extended elimination half-life (typically 63 to 69 hours), allowing for infrequent dosing schedules while maintaining steady-state prolactin control.

Manufactured by Zhengzhou Pharmaceutical Co., Ltd. (ZPHC) under strict cGMP protocols and verified by analytical batch testing, each tablet delivers a precise 0.25mg dose of pure Cabergoline. Store at controlled room temperature, shielded from direct sunlight, thermal variation, and ambient moisture.

Product Attribute Table

Attribute	Specification
Manufacturer / Brand	ZPHC (Zhengzhou Pharmaceutical Co., Ltd.)
Product Name	Cabergoline
Active Substance	Cabergoline (Dostinex)
Chemical Name	1-[(6-allylergolin-8$\beta$-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea
Dosage / Concentration	0.25 mg/tablet
Form	Oral Tablet
Compound Category	Dopamine $D_2$ Receptor Agonist / Prolactin Inhibitor
Storage Requirements	Controlled Room Temperature (15°C – 25°C), Protect strictly from light and ambient moisture